Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials.

Saved in:
Bibliographic Details
Title: Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials.
Authors: Soriano A; Department of Infectious Diseases, Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, CIBERINF, Barcelona, Spain., Thompson GR 3rd; Department of Internal Medicine, Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California, USA.; The Department of Medical Microbiology and Immunology, University of California Davis, Davis, California, USA., Cornely OA; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Division of Infectious Diseases, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany., Bassetti M; University of Genoa and Policlinico San Martino IRCCS Hospital, Genoa, Italy., Kullberg BJ; Department of Medicine, Radboudumc Community for Infectious Diseases and, Radboud University Medical Center, Nijmegen, the Netherlands., Honoré PM; Department of Intensive Care, CHU UCL Godinne, UCLouvain, Site Godinne, Yvoir, Belgium., Dupont H; Department of Anesthesiology and Critical Care Medicine, Amiens-Picardie University Hospital, Amiens, France., Vazquez JA; Medical College of Georgia/Augusta University, Augusta, Georgia, USA., Huang H; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Zhang Y; Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China., Dickerson S; Clinical Development, Mundipharma Research Limited, Cambridge, UK., Cox L; Clinical Development, Mundipharma Research Limited, Cambridge, UK., Pappas PG; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Source: Mycoses [Mycoses] 2026 Jul; Vol. 69 (7), pp. e70205.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Comparative Study
Journal Info: Publisher: Grosse Verlag Country of Publication: Germany NLM ID: 8805008 Publication Model: Print Cited Medium: Internet ISSN: 1439-0507 (Electronic) Linking ISSN: 09337407 NLM ISO Abbreviation: Mycoses Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1439-0507
DOI:10.1111/myc.70205